Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid Discontinuation in Liver Transplant Recipients
NCT00374231Phase 4Completed
- Sponsor
- University of Cincinnati
- Start
- Oct 2002
- Primary completion
- Jan 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus + Wuzhi capsule and mycophenolate mofetil in graft rejection, sponsored by University of Cincinnati. Primary endpoint: Incidence of Biopsy Confirmed Acute Rejection at 12 months. Started Oct 2002; status: completed.
02
Drugs
tacrolimus + Wuzhi capsulemycophenolate mofetil
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT00374231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374231.